[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356343-105":59,"doc-detail-356343-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comparative-analysis-of-prevalences-of-sensorineural-hearing-loss-from-chemoradiotherapy-versus-radiotherapy-in-head-and-neck-cancer-patients-a-systematic-review-and-meta-analysis","Comparative analysis of prevalences of sensorineural hearing loss from chemoradiotherapy versus radiotherapy in head and neck cancer patients - a systematic review and meta-analysis","","Systematic review and meta-analysis evaluates the pooled prevalence of sensorineural hearing loss (SNHL) among head and neck cancer patients receiving chemoradiotherapy (CRT) versus radiotherapy (RT). Searches covered PubMed/MEDLINE, Google Scholar, DOAJ, AJOL, and the Cochrane Library, with additional grey-literature identification via manual Google searching. Studies were screened using preset criteria. Overall pooled prevalence and CRT/RT-specific prevalences were estimated with a REML random-effects model in Jamovi (p\u003C0.05).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparative-analysis-of-prevalences-of-sensorineural-hearing-loss-from-chemoradiotherapy-versus-radiotherapy-in-head-and-neck-cancer-patients-a-systematic-review-and-meta-analysis/356343/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparative-analysis-of-prevalences-of-sensorineural-hearing-loss-from-chemoradiotherapy-versus-radiotherapy-in-head-and-neck-cancer-patients-a-systematic-review-and-meta-analysis/356343.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study?","Question",{"text":112,"@type":113},"To estimate the pooled prevalence of sensorineural hearing loss in head and neck cancer patients treated with chemoradiotherapy versus radiotherapy, using a systematic review and meta-analysis approach.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies identified and selected?",{"text":117,"@type":113},"The review searched PubMed/MEDLINE, Google Scholar, DOAJ, AJOL, and the Cochrane Library using predefined key terms, and performed additional manual Google searches for grey literature. Results were screened and included or excluded based on preset criteria.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings regarding SNHL prevalence?",{"text":121,"@type":113},"Overall SNHL prevalence was 54.5% among patients receiving CRT or RT. Prevalence was higher with CRT (60.4%) than with RT (32.9%). The prevalence ratio indicated nearly twice the risk with CRT compared with RT.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356343,1790228354,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Bukuru and Sibomana BMC Cancer (2026) 26:224 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15551-z](https://doi.org/10.1186/s12885-026-15551-z)  \nRESEARCH Open Access  \nComparative analysis   \nof prevalences of sensorineural hearing loss from chemoradiotherapy versus radiotherapy in head and neck cancer patients: a systematic review and meta-analysis  \nJohn Bukuru 1 and Olivier Sibomana2*  \nAbstract  \nIntroduction Head and neck cancer (HNC) is the seventh most prevalent cancer globally. Chemoradiotherapy (CRT) and radiotherapy (RT) are the two most common treatment modalities for HNC. However, both treatments are associated with adverse side effects, including hearing loss. This systematic review and meta-analysis aim to evaluate the pooled prevalence of sensorineural hearing loss (SNHL) among HNC patients undergoing CRT versus RT. Methodology A comprehensive search of PubMed/MEDLINE, Google Scholar, DOAJ, AJOL, and the Cochrane Library was conducted using predefined key terms to identify original articles reporting the prevalence of SNHL in HNC patients treated with CRT or RT. Additionally, manual Google searches were performed to uncover relevant grey literature. The results were screened and included or excluded according to preset criteria. The Restricted Maximum Likelihood (REML) random-effects model was employed to calculate the overall pooled prevalence and separate prevalences in CRT and RT groups, as well as their respective heterogeneities, using Jamovi 2.3.28 software. Statistical significance was set at p \u003C .05 for all analyses.  \nResults The overall prevalence of SNHL among HNC patients treated with CRT or RT was 54 . 5%(95% CI: 44. 9%− 64 . 0%; I² = 90 . 35%, p \u003C . 001) . For CRT, the prevalence was 60 .4%(95% CI: 50 . 5% − 70 . 2%; I² = 88 . 82%, p \u003C . 001) . In contrast, the prevalence for RT was 32 . 9%(95% CI: 21 . 3% − 44 .4%; I² = 60 . 15%, p = . 063) . The risk of developing SNHL was nearly twice as high in patients treated with CRT compared to those treated with RT alone, with a prevalence ratio of 1.83.  \nConclusion Both CRT and RT are associated with SNHL in HNC patients, with a significantly higher prevalence observed in those undergoing CRT compared to RT.  \nKeywords Hearing loss, Chemotherapy, Radiotherapy, Otolaryngology, Cancer  \n*Correspondence:  \nOlivier Sibomana [oliviersibomana917@gmail.com](oliviersibomana917@gmail.com)  \n1Department of ENT, Rwanda Military Referral and Teaching Hospital, Kigali, Rwanda  \n2Department of General Medicine and Surgery, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nBukuru and Sibomana BMC Cancer (2026) 26:224  \nIntroduction  \nCancer has emerged as a significant global health concern due to the rising mortality and disability rates associated with the disease [1]. In 2022, it was estimated that there were","cbCaivCKOMQ2ZreW","https://ap.wps.com/l/cbCaivCKOMQ2ZreW","pdf",1686676,12,"English","# Introduction\n## Background on head and neck cancer and treatment modalities\n# Methodology\n## Search strategy and study selection\n## Statistical approach and pooled estimates\n# Results\n## Pooled prevalence of SNHL in CRT vs RT\n## Prevalence ratios and heterogeneity\n# Conclusion","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To estimate the pooled prevalence of sensorineural hearing loss in head and neck cancer patients treated with chemoradiotherapy versus radiotherapy, using a systematic review and meta-analysis approach.\"},{\"question\":\"How were studies identified and selected?\",\"answer\":\"The review searched PubMed/MEDLINE, Google Scholar, DOAJ, AJOL, and the Cochrane Library using predefined key terms, and performed additional manual Google searches for grey literature. Results were screened and included or excluded based on preset criteria.\"},{\"question\":\"What were the key findings regarding SNHL prevalence?\",\"answer\":\"Overall SNHL prevalence was 54.5% among patients receiving CRT or RT. Prevalence was higher with CRT (60.4%) than with RT (32.9%). The prevalence ratio indicated nearly twice the risk with CRT compared with RT.\"}]","Comparative analysis of prevalences of sensorineural hearing loss from chemoradiotherapy versus radiotherapy in head and neck cancer patients - a systematic review and meta-analysis | PDF",1790124931,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29b1acddf2db4d7de394e0873958056f.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1992f197530944b5d5147cdfa6a632f5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89e517dc940ae5dbad892a70f2251069.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfc88f89aff8d4b8f9600c302b99512e.webp",980,1306]